Neumora Therapeutics, Inc. (NMRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.15 |
| Open | 9.19 |
| Bid | 9.44 x 100 |
| Ask | 9.48 x 100 |
| Day's range | 9.19 - 9.74 |
| 52-week range | 8.82 - 21.00 |
| Volume | |
| Avg. volume | 573,675 |
| Market cap | 1.508B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.63 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 25.25 |
Simply Wall St.We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ZacksBiotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
ZacksNeumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
The FDA places a clinical hold on Neumora's (NMRA) phase I study evaluating NMRA-266 for some types of neuropsychiatric disorders. Shares of the company fall on the news.
© 2024 Yahoo. All rights reserved.